04 Oct 2025 | 5 Mins Read
Lupin gets US FDA approval for Pithampur Unit 2
Flipitmoney
Lupin's Pithampur Unit 2 manufacturing facility was inspected by the US FDA from July 8-17, 2025, and classified as 'Official Action Indicated' due to four observations. Lupin will work with the US regulator to resolve compliance issues. Separately, Lupin launched Liraglutide injection to help control blood sugar in the US, which is a $350 million market annually.